rs181990653
Positions:
Variant summary
Our verdict is Benign. Variant got -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BS1BS2
The NM_153460.4(IL17RC):āc.1812C>Gā(p.Gly604Gly) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00147 in 1,605,280 control chromosomes in the GnomAD database, including 26 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (ā ā ).
Frequency
Genomes: š 0.0018 ( 4 hom., cov: 33)
Exomes š: 0.0014 ( 22 hom. )
Consequence
IL17RC
NM_153460.4 synonymous
NM_153460.4 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.178
Genes affected
IL17RC (HGNC:18358): (interleukin 17 receptor C) This gene encodes a single-pass type I membrane protein that shares similarity with the interleukin-17 receptor (IL-17RA). Unlike IL-17RA, which is predominantly expressed in hemopoietic cells, and binds with high affinity to only IL-17A, this protein is expressed in nonhemopoietic tissues, and binds both IL-17A and IL-17F with similar affinities. The proinflammatory cytokines, IL-17A and IL-17F, have been implicated in the progression of inflammatory and autoimmune diseases. Multiple alternatively spliced transcript variants encoding different isoforms have been detected for this gene, and it has been proposed that soluble, secreted proteins lacking transmembrane and intracellular domains may function as extracellular antagonists to cytokine signaling. [provided by RefSeq, Feb 2011]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -21 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.8).
BP6
Variant 3-9933242-C-G is Benign according to our data. Variant chr3-9933242-C-G is described in ClinVar as [Benign]. Clinvar id is 475924.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-0.178 with no splicing effect.
BS1
Variant frequency is greater than expected in population amr. gnomad4_exome allele frequency = 0.00144 (2087/1452928) while in subpopulation AMR AF= 0.0216 (950/43916). AF 95% confidence interval is 0.0205. There are 22 homozygotes in gnomad4_exome. There are 1133 alleles in male gnomad4_exome subpopulation. Median coverage is 34. This position pass quality control queck.
BS2
High Homozygotes in GnomAd4 at 4 AR gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
IL17RC | NM_153460.4 | c.1812C>G | p.Gly604Gly | synonymous_variant | 19/19 | ENST00000403601.8 | NP_703190.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
IL17RC | ENST00000403601.8 | c.1812C>G | p.Gly604Gly | synonymous_variant | 19/19 | 1 | NM_153460.4 | ENSP00000384969.3 | ||
ENSG00000288550 | ENST00000683484.1 | n.1399+539C>G | intron_variant | ENSP00000507040.1 |
Frequencies
GnomAD3 genomes AF: 0.00175 AC: 267AN: 152234Hom.: 3 Cov.: 33
GnomAD3 genomes
AF:
AC:
267
AN:
152234
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00480 AC: 1092AN: 227580Hom.: 12 AF XY: 0.00445 AC XY: 554AN XY: 124578
GnomAD3 exomes
AF:
AC:
1092
AN:
227580
Hom.:
AF XY:
AC XY:
554
AN XY:
124578
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00144 AC: 2087AN: 1452928Hom.: 22 Cov.: 34 AF XY: 0.00157 AC XY: 1133AN XY: 722216
GnomAD4 exome
AF:
AC:
2087
AN:
1452928
Hom.:
Cov.:
34
AF XY:
AC XY:
1133
AN XY:
722216
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00177 AC: 269AN: 152352Hom.: 4 Cov.: 33 AF XY: 0.00207 AC XY: 154AN XY: 74500
GnomAD4 genome
AF:
AC:
269
AN:
152352
Hom.:
Cov.:
33
AF XY:
AC XY:
154
AN XY:
74500
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
18
AN:
3476
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
Candidiasis, familial, 9 Benign:1
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 31, 2024 | - - |
not provided Benign:1
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at